[Press Release] Himeji City Becomes the First Government Body to Join AMR Alliance Japan – Following the 72nd Session of the World Health Organization Regional Committee for the Western Pacific, held in Himeji City, the City Government announced its participation in AMR Alliance Japan (November 17, 2021)
date : 11/17/2021
Tags: AMR
Himeji City announced its intention to join AMR Alliance Japan during a press conference held after the 72nd session of the World Health Organization Regional Committee for the Western Pacific (held in Himeji City from November 25 to November 29, 2021). The announcement makes Himeji City the first Government body to join the Alliance. Hideyasu Kiyomoto, the Mayor of Himeji City commented that Himeji City was going to consider serious steps to tackle the problem of AMR.
On September 25, 2021, prior to the World Health Organization Regional Committee for the Western Pacific, AMR Alliance Japan, Himeji City, Himeji Medical Association, and Himeji Dental Association hosted an official related event, “AMR: A Global Health Crisis -What We Can Do for the Fight Against the Silent Pandemic of AMR: Learning from COVID-19.” This event was supported by Ministry of Health, Labour and Welfare, Himeji Pharmacist Association and Hyogo Nursing Association Seiban Branch, and sponsored by Japan Pharmaceutical Manufacturers Association. The event stressed the urgency of AMR as a worldwide health crisis, and called for policy action at the global and local level.
Together with Himeji City and all of its members, AMR Alliance Japan will continue to promote the creation of stronger countermeasures against AMR through broad-based multisector collaboration.
■About AMR Alliance Japan AMR
AMR Alliance Japan was established in November 2018 as multi-stakeholder, collaborative organization dedicated to the improvement of public health through the promotion of AMR countermeasures. As of November 2021, its members include, in alphabetical order: Himeji City; The Japanese Association for Infectious Diseases; The Japanese Society for Chemotherapy; The Japanese Society for Clinical Microbiology; The Japanese Society for Medical Mycology; The Japanese Society for Pediatric Infectious Diseases; The Japanese Society of Infection Prevention and Control; The Japanese Society of Pharmaceutical Health Care and Sciences; The Japanese Society of Therapeutic Drug Monitoring; The Japan Medical Association; The Japan Pharmaceutical Association; The Japan Pharmaceutical Manufacturers Association; The Japan Society of Hospital Pharmacists; “Kodomo to Iryo” Project; MSD K.K.; Nippon Becton Dickinson Co., Ltd.; Pfizer Inc.; The Pharmaceutical Society of Japan; Shionogi & Co., Ltd. The Health and Global Policy Institute serves as the Secretariat of AMR Alliance Japan. Please scan the QR code at right to see our AMR Alliance Japan Website.
■Spreading Awareness about AMR in the Month of November
In Japan, the Cabinet Secretariat has designated November as “Antimicrobial Resistance (AMR) Awareness Month.” This aligns with “World Antimicrobial Awareness Week(WAAW),” which has been set for November 18 to November 24 this year by the WHO. This year’s theme is “Spread Awareness, Stop Resistance.”
日本語
Top Research & Recommendations Posts
- [Announcement] A Turning Point Towards Building Green Healthcare Systems (June 5, 2024)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Publication Report] Guidance on Patient and Public Involvement (PPI) in Health Policymaking: Necessary Initiatives and Good Examples from the Public and Government (March 31, 2024)
- [Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
- [Research Report] Healthcare DX Project Research Report of Interviews ”Expectations for the Coming Era of Healthcare DX from People Living with Health Concerns” (June 10, 2024)
- [Policy Recommendations] Recommendation for the Basic Policy on Economic and Fiscal Management and Reform 2024 (June 11, 2024)
- [Policy Recommendations] Kidney Disease Control Promotion Project 2023 “Establishing Kidney Disease Control Measures with Patient, Citizen, and Community Engagement and Collaboration” Policy Recommendations, a Collection of Good Practices of Chronic Kidney Disease (CKD) and Control Measures in Local Governments (February 14, 2024)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Public Comment Submission] Web based consultations on NCDs and mental health by World Health Organization (June 25, 2024)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
Featured Posts
-
2024-06-21
[Event Report] HGPI Special Seminar – HGPI Celebrates its 20th Anniversary: Reflecting on HGPI’s Journey from the Past to the Future (January 16, 2024)
-
2024-06-25
[Public Comment Submission] Web based consultations on NCDs and mental health by World Health Organization (June 25, 2024)
-
2024-06-26
[Event Report] Global Expert Meeting “Innovation in Cancer Care in Developing Countries ~City Cancer Challenge Initiatives“ (June 20, 2024)
-
2024-06-26
[Registration Open] (Webinar) The 127th HGPI Seminar: Current Issues and Future Prospects in Establishing a Health System and Protecting Public Health Through Policy (July 18, 2024)
-
2024-07-01
[Registration Open] Meaningful Involvement Promotion Project Online Expert Meeting “Shaping the Future of Health Policy with People with Lived Experience and Citizens” (July 26, 2024)